Arvinas Surges 5.51% as Investors Embrace Its Protein‑Degradation Breakthrough
Arvinas rallies 5.51% amid market volatility, showcasing the biotech’s protein‑degradation platform as a high‑growth catalyst for investors.
3 minutes to read
ARVINAS INC